US 9402840
Crystalline form of a quinolinone-carboxamide compound
granted A61KA61K31/46A61P
Quick answer
US patent 9402840 (Crystalline form of a quinolinone-carboxamide compound) held by Theravance Biopharma R&D IP, LLC expires Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Aug 02 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/46, A61P, A61P1/00, A61P1/04